AOP Orphan Pharmaceuticals

We at AOP Orphan are European pioneers in the field of Orphan Diseases. We research, develop, produce, and distribute innovative solutions for Rare Diseases worldwide. Dr. Rudolf Widmann established AOP Orphan in Vienna in 1996 in order to provide individualized treatment for patients suffering from Rare Diseases. AOP Orphan has focused particularly on the areas of hematology and oncology, cardiology, neurology, psychiatry and metabolic diseases. Thanks to years of experience in providing complex individualized treatment, AOP Orphan has acquired significant expertise and developed a strong market presence in the field of Orphan Diseases. The fact that AOP Orphan is privately owned assures a long-term engagement in the market along with high quality services and products. AOP Orphan is also the only provider of key therapies for certain special indications. Data protection information: https://www.aoporphan.com/data-protection.html